These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34768908)

  • 21. Efficacy of Chinese herbal medicine for tPA thrombolysis in experimental stroke: A systematic review and meta-analysis.
    Ye Y; Zhu YT; Xin XY; Zhang JC; Zhang HL; Li D
    Phytomedicine; 2022 Jun; 100():154072. PubMed ID: 35349833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
    Fukuta T
    Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.
    Suzuki Y; Nagai N; Umemura K
    J Pharmacol Sci; 2011; 116(1):25-9. PubMed ID: 21498957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
    Novokhatny VV; Jesmok GJ; Landskroner KA; Marder VJ; Zimmerman TP
    Trends Pharmacol Sci; 2004 Feb; 25(2):72-5. PubMed ID: 15102492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.
    Shlansky-Goldberg RD; Matsumoto AH; Baumbach GA; Siegel JB; Raabe RD; Murphy TP; Deng C; Ray Dawkins J; Marder VJ
    J Thromb Haemost; 2008 Jun; 6(6):944-50. PubMed ID: 18384651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.
    Zhao XJ; Larkin TM; Lauver MA; Ahmad S; Ducruet AF
    PLoS One; 2017; 12(7):e0180822. PubMed ID: 28700732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
    Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
    J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes.
    Navarro-Oviedo M; Roncal C; Salicio A; Belzunce M; Rabal O; Toledo E; Zandio B; Rodríguez JA; Páramo JA; Muñoz R; Orbe J
    Transl Stroke Res; 2019 Aug; 10(4):389-401. PubMed ID: 30051168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke.
    Draxler DF; Lee F; Ho H; Keragala CB; Medcalf RL; Niego B
    Front Immunol; 2019; 10():591. PubMed ID: 30972077
    [No Abstract]   [Full Text] [Related]  

  • 33. Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA.
    Li C; Wang C; Zhang Y; Alsrouji OK; Chebl AB; Ding G; Jiang Q; Mayer SA; Lu M; Kole MK; Marin HL; Zhang L; Chopp M; Zhang ZG
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2090-2104. PubMed ID: 33557693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
    Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
    Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
    Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
    Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety evaluation of a recombinant plasmin derivative lacking kringles 2-5 and rt-PA in a rat model of transient ischemic stroke.
    Crumrine RC; Marder VJ; Taylor GM; LaManna JC; Tsipis CP; Novokhatny V; Scuderi P; Petteway SR; Arora V
    Exp Transl Stroke Med; 2012 May; 4(1):10. PubMed ID: 22591588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fibrin targeted molecular imaging evaluation of microvascular no-reflow in acute ischemic stroke.
    Chen X; Wang J; Ge L; Lu G; Wan H; Jiang Y; Yao Z; Deng G; Zhang X
    Brain Behav; 2022 Feb; 12(2):e2474. PubMed ID: 35025138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.